March 16, 2023 — Today, AxoSim celebrated the expansion of their footprint with the New Orleans BioInnovation Center (NOBIC) at a ribbon cutting at 1441 Canal Street. The event, followed by a reception in the NOBIC lobby, was attended by BioDistrict supporters including elected officials, business organizations and board members from both entities.
The new partnership expands AxoSim’s current operation to more than 4,000 square feet at the NOBIC facility in the heart of the downtown BioDistrict. The additional lab space will allow AxoSim to grow its neuroscience drug discovery operations and accelerate their mission of empowering advancements in human neuroscience. The company’s proprietary NerveSim® and BrainSim® platforms provide accurate, predictive models of the human nervous system, rapidly delivering clinically actionable human data early in the drug development process. AxoSim’s platforms have the potential to reduce the time and cost of new drug R&D for neurodegenerative disorders, in addition to its applications in toxicology. The technology has been shown to achieve research milestones at a fraction of the time and cost of conventional animal testing, allowing AxoSim’s biopharma partners to develop more effective and safer drugs with greater speed and efficiency.